HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies
- PMID: 27043631
- PMCID: PMC4846850
- DOI: 10.3390/cancers8040041
HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies
Abstract
Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous disease that is the result of tobacco and/or alcohol abuse or infection with high-risk Human papillomaviruses. Despite the fact that HPV positive HNSCC cancers form a distinct clinical entity with better treatment outcome, all HNSCC are currently treated uniformly with the same treatment modality. At present, biologic basis of these different outcomes and their therapeutic influence are areas of intense investigation. In this review, we will summarize the molecular basis for this different outcome, novel treatment opportunities and possible biomarkers for HPV positive HNSCC. In particular, the focus will be on several molecular targeted strategies that can improve the chemoradiation response by influencing DNA repair mechanisms.
Keywords: HPV; head and neck cancer; molecular pathogenesis; radiation therapy.
Figures
Similar articles
-
Novel insights into head and neck cancer using next-generation "omic" technologies.Cancer Res. 2015 Feb 1;75(3):480-6. doi: 10.1158/0008-5472.CAN-14-3124. Epub 2015 Jan 14. Cancer Res. 2015. PMID: 25589349 Review.
-
The Role of Biomarkers in HPV-Positive Head and Neck Squamous Cell Carcinoma: Towards Precision Medicine.Diagnostics (Basel). 2024 Jul 7;14(13):1448. doi: 10.3390/diagnostics14131448. Diagnostics (Basel). 2024. PMID: 39001338 Free PMC article. Review.
-
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.Cancer. 2017 May 15;123(10):1778-1790. doi: 10.1002/cncr.30570. Epub 2017 Mar 13. Cancer. 2017. PMID: 28295222 Free PMC article.
-
Human papillomavirus-related head and neck tumors: clinical and research implication.Curr Opin Oncol. 2009 May;21(3):201-5. doi: 10.1097/cco.0b013e328329ab64. Curr Opin Oncol. 2009. PMID: 19370803 Review.
-
MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.Cancer Biomark. 2015;15(3):213-8. doi: 10.3233/CBM-150464. Cancer Biomark. 2015. PMID: 25769448 Review.
Cited by
-
Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas.Int J Cancer. 2020 Feb 15;146(4):1075-1085. doi: 10.1002/ijc.32558. Epub 2019 Jul 27. Int J Cancer. 2020. PMID: 31283004 Free PMC article.
-
Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer.Cancers (Basel). 2018 Jun 21;10(7):210. doi: 10.3390/cancers10070210. Cancers (Basel). 2018. PMID: 29933636 Free PMC article. Review.
-
Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2.Cancers (Basel). 2020 Mar 26;12(4):792. doi: 10.3390/cancers12040792. Cancers (Basel). 2020. PMID: 32224897 Free PMC article.
-
Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.Oncol Lett. 2017 May;13(5):3269-3276. doi: 10.3892/ol.2017.5844. Epub 2017 Mar 13. Oncol Lett. 2017. PMID: 28521433 Free PMC article.
-
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.Clin Epigenetics. 2017 Feb 2;9:12. doi: 10.1186/s13148-017-0317-7. eCollection 2017. Clin Epigenetics. 2017. PMID: 28174607 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources